What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Cancer
Mark L. Kahn mainly investigates Cell biology, Receptor, Platelet, Molecular biology and Platelet activation.
His Cell biology study combines topics in areas such as PDPN, Podoplanin, Immunology, Endothelium and Protease-activated receptor.
The study incorporates disciplines such as Endothelial stem cell and Signal transduction in addition to Receptor.
His work in GPVI and Platelet membrane glycoprotein are all subfields of Platelet research.
His study in the fields of Convulxin under the domain of GPVI overlaps with other disciplines such as Linker for Activation of T cells.
His Molecular biology research is multidisciplinary, relying on both Secretion, A549 cell, Gene expression and Transfection.
His most cited work include:
- A dual thrombin receptor system for platelet activation (873 citations)
- Protease-activated receptor 3 is a second thrombin receptor in humans. (790 citations)
- Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin (691 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Cell biology, Platelet, Receptor, GPVI and Signal transduction.
The concepts of his Cell biology study are interwoven with issues in Endothelial stem cell, Biochemistry, Lymphatic system and Protease-activated receptor, Thrombin.
Mark L. Kahn has researched Protease-activated receptor in several fields, including Inflammation and Thrombin receptor.
His Platelet research includes themes of Collagen receptor and Integrin.
His GPVI research is multidisciplinary, incorporating elements of Immune receptor, Calmodulin and Fc receptor.
His studies deal with areas such as Function and Phosphorylation as well as Signal transduction.
He most often published in these fields:
- Cell biology (47.53%)
- Platelet (35.80%)
- Receptor (27.16%)
What were the highlights of his more recent work (between 2017-2021)?
- Cell biology (47.53%)
- Lymphatic system (17.90%)
- Pathology (13.58%)
In recent papers he was focusing on the following fields of study:
Mark L. Kahn focuses on Cell biology, Lymphatic system, Pathology, Cancer research and Transcription factor.
His work carried out in the field of Cell biology brings together such families of science as Receptor, Stimulation and FOXC2.
While the research belongs to areas of Receptor, Mark L. Kahn spends his time largely on the problem of Zebrafish, intersecting his research to questions surrounding CXCR4 and Chemokine.
His Lymphatic system study combines topics in areas such as Endothelial stem cell, Vascular endothelial growth factor C, Lung and Lymphangiogenesis.
His biological study spans a wide range of topics, including Hemostasis, Wound healing and Platelet activation, Platelet, Thrombin.
His Pathology study combines topics from a wide range of disciplines, such as Cerebral cavernous malformations, Lung injury, Immune system and Mutation.
Between 2017 and 2021, his most popular works were:
- Mechanically activated ion channel PIEZO1 is required for lymphatic valve formation (76 citations)
- Neutrophil accumulation and NET release contribute to thrombosis in HIT (50 citations)
- Lymphatic impairment leads to pulmonary tertiary lymphoid organ formation and alveolar damage (22 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Cancer
Mark L. Kahn mainly focuses on Pathology, Cell biology, Lymphatic system, Protein kinase A and Lymph.
His studies in Pathology integrate themes in fields like Mutation and Familial cerebral cavernous malformation.
His research in Cell biology is mostly concerned with Hippo signaling pathway.
The Lymphatic system study combines topics in areas such as Hennekam syndrome, Lung injury and Cell polarity.
His study in Protein kinase A is interdisciplinary in nature, drawing from both Lesion, Myosin light-chain kinase, Hindbrain, Somatic cell and Phenotype.
His study in the field of Lymphatic Endothelium also crosses realms of PIEZO1.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
